- 专利标题： TARGETED THERAPEUTIC AGENTS AND USES THEREOF
-
申请号： EP17704697.6申请日： 2017-02-06
-
公开(公告)号： EP3411398A2公开(公告)日： 2018-12-12
- 发明人: TAVERNIER, Jan , KLEY, Nikolai
- 申请人： Orionis Biosciences NV , VIB VZW , Universiteit Gent
- 申请人地址： Rijvisschestraat 120 9052 Zwijnaarde BE
- 专利权人： Orionis Biosciences NV,VIB VZW,Universiteit Gent
- 当前专利权人： Orionis Biosciences NV,VIB VZW,Universiteit Gent
- 当前专利权人地址： Rijvisschestraat 120 9052 Zwijnaarde BE
- 代理机构： Grund, Martin
- 优先权： US201662291769P 20160205; US201662291772P 20160205; US201662291774P 20160205; US201662291776P 20160205; US201662291779P 20160205; US201662335880P 20160513; US201662335965P 20160513; US201662335968P 20160513; US201662335979P 20160513; US201662336030P 20160513; US201662353607P 20160623; US201662411805P 20161024
- 国际公布： WO2017134302 20170810
- 主分类号： C07K16/00
- IPC分类号： C07K16/00 ; C07K16/24 ; C07K16/28
摘要：
The present invention relates, in part, to agents that bind Clec9Aand their use as diagnostic and therapeutic agents.The present invention further relates to pharmaceutical compositions comprising the Clec9A binding agents and their use in the treatment of various diseases.
公开/授权文献
- EP3411398B1 TARGETED THERAPEUTIC AGENTS AND USES THEREOF 公开/授权日：2024-04-03
信息查询
